The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Thrombin (Human) Market Research Report 2025
Synopsis
The global Thrombin (Human) market was valued at US$ 565 million in 2023 and is anticipated to reach US$ 704.7 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Thrombin (Human), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thrombin (Human).
Report Scope
The Thrombin (Human) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thrombin (Human) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thrombin (Human) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
AMRESCO Inc
BD Biosciences
Life Technologies Corporation
PromoCell GmbH
Sigma-Aldrich Corporation
Vitrolife AB
CSL
Bayer
Grifols
Octapharma
Shanghai RAAS
Hualan Biological
Kedrion
Segment by Type
500IU/Vial
1000IU/Vial
2500IU/Vial
Segment by Application
Biotechnology
Medicine
Microbiology
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Thrombin (Human) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Thrombin (Human) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Thrombin (Human) market was valued at US$ 565 million in 2023 and is anticipated to reach US$ 704.7 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Thrombin (Human), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thrombin (Human).
Report Scope
The Thrombin (Human) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thrombin (Human) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thrombin (Human) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
AMRESCO Inc
BD Biosciences
Life Technologies Corporation
PromoCell GmbH
Sigma-Aldrich Corporation
Vitrolife AB
CSL
Bayer
Grifols
Octapharma
Shanghai RAAS
Hualan Biological
Kedrion
Segment by Type
500IU/Vial
1000IU/Vial
2500IU/Vial
Segment by Application
Biotechnology
Medicine
Microbiology
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Thrombin (Human) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Thrombin (Human) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Thrombin (Human) Market Overview
1.1 Product Overview and Scope of Thrombin (Human)
1.2 Thrombin (Human) Segment by Type
1.2.1 Global Thrombin (Human) Market Value Comparison by Type (2024-2030)
1.2.2 500IU/Vial
1.2.3 1000IU/Vial
1.2.4 2500IU/Vial
1.3 Thrombin (Human) Segment by Application
1.3.1 Global Thrombin (Human) Market Value by Application: (2024-2030)
1.3.2 Biotechnology
1.3.3 Medicine
1.3.4 Microbiology
1.3.5 Others
1.4 Global Thrombin (Human) Market Size Estimates and Forecasts
1.4.1 Global Thrombin (Human) Revenue 2019-2030
1.4.2 Global Thrombin (Human) Sales 2019-2030
1.4.3 Global Thrombin (Human) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Thrombin (Human) Market Competition by Manufacturers
2.1 Global Thrombin (Human) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Thrombin (Human) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Thrombin (Human) Average Price by Manufacturers (2019-2024)
2.4 Global Thrombin (Human) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Thrombin (Human), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Thrombin (Human), Product Type & Application
2.7 Thrombin (Human) Market Competitive Situation and Trends
2.7.1 Thrombin (Human) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Thrombin (Human) Players Market Share by Revenue
2.7.3 Global Thrombin (Human) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Thrombin (Human) Retrospective Market Scenario by Region
3.1 Global Thrombin (Human) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Thrombin (Human) Global Thrombin (Human) Sales by Region: 2019-2030
3.2.1 Global Thrombin (Human) Sales by Region: 2019-2024
3.2.2 Global Thrombin (Human) Sales by Region: 2025-2030
3.3 Global Thrombin (Human) Global Thrombin (Human) Revenue by Region: 2019-2030
3.3.1 Global Thrombin (Human) Revenue by Region: 2019-2024
3.3.2 Global Thrombin (Human) Revenue by Region: 2025-2030
3.4 North America Thrombin (Human) Market Facts & Figures by Country
3.4.1 North America Thrombin (Human) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Thrombin (Human) Sales by Country (2019-2030)
3.4.3 North America Thrombin (Human) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Thrombin (Human) Market Facts & Figures by Country
3.5.1 Europe Thrombin (Human) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Thrombin (Human) Sales by Country (2019-2030)
3.5.3 Europe Thrombin (Human) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Thrombin (Human) Market Facts & Figures by Country
3.6.1 Asia Pacific Thrombin (Human) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Thrombin (Human) Sales by Country (2019-2030)
3.6.3 Asia Pacific Thrombin (Human) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Thrombin (Human) Market Facts & Figures by Country
3.7.1 Latin America Thrombin (Human) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Thrombin (Human) Sales by Country (2019-2030)
3.7.3 Latin America Thrombin (Human) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Thrombin (Human) Market Facts & Figures by Country
3.8.1 Middle East and Africa Thrombin (Human) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Thrombin (Human) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Thrombin (Human) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Thrombin (Human) Sales by Type (2019-2030)
4.1.1 Global Thrombin (Human) Sales by Type (2019-2024)
4.1.2 Global Thrombin (Human) Sales by Type (2025-2030)
4.1.3 Global Thrombin (Human) Sales Market Share by Type (2019-2030)
4.2 Global Thrombin (Human) Revenue by Type (2019-2030)
4.2.1 Global Thrombin (Human) Revenue by Type (2019-2024)
4.2.2 Global Thrombin (Human) Revenue by Type (2025-2030)
4.2.3 Global Thrombin (Human) Revenue Market Share by Type (2019-2030)
4.3 Global Thrombin (Human) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Thrombin (Human) Sales by Application (2019-2030)
5.1.1 Global Thrombin (Human) Sales by Application (2019-2024)
5.1.2 Global Thrombin (Human) Sales by Application (2025-2030)
5.1.3 Global Thrombin (Human) Sales Market Share by Application (2019-2030)
5.2 Global Thrombin (Human) Revenue by Application (2019-2030)
5.2.1 Global Thrombin (Human) Revenue by Application (2019-2024)
5.2.2 Global Thrombin (Human) Revenue by Application (2025-2030)
5.2.3 Global Thrombin (Human) Revenue Market Share by Application (2019-2030)
5.3 Global Thrombin (Human) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Thrombin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Baxter Thrombin (Human) Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 AMRESCO Inc
6.2.1 AMRESCO Inc Corporation Information
6.2.2 AMRESCO Inc Description and Business Overview
6.2.3 AMRESCO Inc Thrombin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AMRESCO Inc Thrombin (Human) Product Portfolio
6.2.5 AMRESCO Inc Recent Developments/Updates
6.3 BD Biosciences
6.3.1 BD Biosciences Corporation Information
6.3.2 BD Biosciences Description and Business Overview
6.3.3 BD Biosciences Thrombin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BD Biosciences Thrombin (Human) Product Portfolio
6.3.5 BD Biosciences Recent Developments/Updates
6.4 Life Technologies Corporation
6.4.1 Life Technologies Corporation Corporation Information
6.4.2 Life Technologies Corporation Description and Business Overview
6.4.3 Life Technologies Corporation Thrombin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Life Technologies Corporation Thrombin (Human) Product Portfolio
6.4.5 Life Technologies Corporation Recent Developments/Updates
6.5 PromoCell GmbH
6.5.1 PromoCell GmbH Corporation Information
6.5.2 PromoCell GmbH Description and Business Overview
6.5.3 PromoCell GmbH Thrombin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 PromoCell GmbH Thrombin (Human) Product Portfolio
6.5.5 PromoCell GmbH Recent Developments/Updates
6.6 Sigma-Aldrich Corporation
6.6.1 Sigma-Aldrich Corporation Corporation Information
6.6.2 Sigma-Aldrich Corporation Description and Business Overview
6.6.3 Sigma-Aldrich Corporation Thrombin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sigma-Aldrich Corporation Thrombin (Human) Product Portfolio
6.6.5 Sigma-Aldrich Corporation Recent Developments/Updates
6.7 Vitrolife AB
6.6.1 Vitrolife AB Corporation Information
6.6.2 Vitrolife AB Description and Business Overview
6.6.3 Vitrolife AB Thrombin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Vitrolife AB Thrombin (Human) Product Portfolio
6.7.5 Vitrolife AB Recent Developments/Updates
6.8 CSL
6.8.1 CSL Corporation Information
6.8.2 CSL Description and Business Overview
6.8.3 CSL Thrombin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CSL Thrombin (Human) Product Portfolio
6.8.5 CSL Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Corporation Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Thrombin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bayer Thrombin (Human) Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 Grifols
6.10.1 Grifols Corporation Information
6.10.2 Grifols Description and Business Overview
6.10.3 Grifols Thrombin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Grifols Thrombin (Human) Product Portfolio
6.10.5 Grifols Recent Developments/Updates
6.11 Octapharma
6.11.1 Octapharma Corporation Information
6.11.2 Octapharma Thrombin (Human) Description and Business Overview
6.11.3 Octapharma Thrombin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Octapharma Thrombin (Human) Product Portfolio
6.11.5 Octapharma Recent Developments/Updates
6.12 Shanghai RAAS
6.12.1 Shanghai RAAS Corporation Information
6.12.2 Shanghai RAAS Thrombin (Human) Description and Business Overview
6.12.3 Shanghai RAAS Thrombin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shanghai RAAS Thrombin (Human) Product Portfolio
6.12.5 Shanghai RAAS Recent Developments/Updates
6.13 Hualan Biological
6.13.1 Hualan Biological Corporation Information
6.13.2 Hualan Biological Thrombin (Human) Description and Business Overview
6.13.3 Hualan Biological Thrombin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hualan Biological Thrombin (Human) Product Portfolio
6.13.5 Hualan Biological Recent Developments/Updates
6.14 Kedrion
6.14.1 Kedrion Corporation Information
6.14.2 Kedrion Thrombin (Human) Description and Business Overview
6.14.3 Kedrion Thrombin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Kedrion Thrombin (Human) Product Portfolio
6.14.5 Kedrion Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Thrombin (Human) Industry Chain Analysis
7.2 Thrombin (Human) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Thrombin (Human) Production Mode & Process
7.4 Thrombin (Human) Sales and Marketing
7.4.1 Thrombin (Human) Sales Channels
7.4.2 Thrombin (Human) Distributors
7.5 Thrombin (Human) Customers
8 Thrombin (Human) Market Dynamics
8.1 Thrombin (Human) Industry Trends
8.2 Thrombin (Human) Market Drivers
8.3 Thrombin (Human) Market Challenges
8.4 Thrombin (Human) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Thrombin (Human) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Thrombin (Human) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Thrombin (Human) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Thrombin (Human) Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Thrombin (Human) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Thrombin (Human) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Thrombin (Human) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Thrombin (Human) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Thrombin (Human), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Thrombin (Human), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Thrombin (Human), Product Type & Application
Table 12. Global Key Manufacturers of Thrombin (Human), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Thrombin (Human) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thrombin (Human) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Thrombin (Human) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Thrombin (Human) Sales by Region (2019-2024) & (K Units)
Table 18. Global Thrombin (Human) Sales Market Share by Region (2019-2024)
Table 19. Global Thrombin (Human) Sales by Region (2025-2030) & (K Units)
Table 20. Global Thrombin (Human) Sales Market Share by Region (2025-2030)
Table 21. Global Thrombin (Human) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Thrombin (Human) Revenue Market Share by Region (2019-2024)
Table 23. Global Thrombin (Human) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Thrombin (Human) Revenue Market Share by Region (2025-2030)
Table 25. North America Thrombin (Human) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Thrombin (Human) Sales by Country (2019-2024) & (K Units)
Table 27. North America Thrombin (Human) Sales by Country (2025-2030) & (K Units)
Table 28. North America Thrombin (Human) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Thrombin (Human) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Thrombin (Human) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Thrombin (Human) Sales by Country (2019-2024) & (K Units)
Table 32. Europe Thrombin (Human) Sales by Country (2025-2030) & (K Units)
Table 33. Europe Thrombin (Human) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Thrombin (Human) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Thrombin (Human) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Thrombin (Human) Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Thrombin (Human) Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Thrombin (Human) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Thrombin (Human) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Thrombin (Human) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Thrombin (Human) Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Thrombin (Human) Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Thrombin (Human) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Thrombin (Human) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Thrombin (Human) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Thrombin (Human) Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Thrombin (Human) Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Thrombin (Human) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Thrombin (Human) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Thrombin (Human) Sales (K Units) by Type (2019-2024)
Table 51. Global Thrombin (Human) Sales (K Units) by Type (2025-2030)
Table 52. Global Thrombin (Human) Sales Market Share by Type (2019-2024)
Table 53. Global Thrombin (Human) Sales Market Share by Type (2025-2030)
Table 54. Global Thrombin (Human) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Thrombin (Human) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Thrombin (Human) Revenue Market Share by Type (2019-2024)
Table 57. Global Thrombin (Human) Revenue Market Share by Type (2025-2030)
Table 58. Global Thrombin (Human) Price (USD/Unit) by Type (2019-2024)
Table 59. Global Thrombin (Human) Price (USD/Unit) by Type (2025-2030)
Table 60. Global Thrombin (Human) Sales (K Units) by Application (2019-2024)
Table 61. Global Thrombin (Human) Sales (K Units) by Application (2025-2030)
Table 62. Global Thrombin (Human) Sales Market Share by Application (2019-2024)
Table 63. Global Thrombin (Human) Sales Market Share by Application (2025-2030)
Table 64. Global Thrombin (Human) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Thrombin (Human) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Thrombin (Human) Revenue Market Share by Application (2019-2024)
Table 67. Global Thrombin (Human) Revenue Market Share by Application (2025-2030)
Table 68. Global Thrombin (Human) Price (USD/Unit) by Application (2019-2024)
Table 69. Global Thrombin (Human) Price (USD/Unit) by Application (2025-2030)
Table 70. Baxter Corporation Information
Table 71. Baxter Description and Business Overview
Table 72. Baxter Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Baxter Thrombin (Human) Product
Table 74. Baxter Recent Developments/Updates
Table 75. AMRESCO Inc Corporation Information
Table 76. AMRESCO Inc Description and Business Overview
Table 77. AMRESCO Inc Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. AMRESCO Inc Thrombin (Human) Product
Table 79. AMRESCO Inc Recent Developments/Updates
Table 80. BD Biosciences Corporation Information
Table 81. BD Biosciences Description and Business Overview
Table 82. BD Biosciences Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. BD Biosciences Thrombin (Human) Product
Table 84. BD Biosciences Recent Developments/Updates
Table 85. Life Technologies Corporation Corporation Information
Table 86. Life Technologies Corporation Description and Business Overview
Table 87. Life Technologies Corporation Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Life Technologies Corporation Thrombin (Human) Product
Table 89. Life Technologies Corporation Recent Developments/Updates
Table 90. PromoCell GmbH Corporation Information
Table 91. PromoCell GmbH Description and Business Overview
Table 92. PromoCell GmbH Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. PromoCell GmbH Thrombin (Human) Product
Table 94. PromoCell GmbH Recent Developments/Updates
Table 95. Sigma-Aldrich Corporation Corporation Information
Table 96. Sigma-Aldrich Corporation Description and Business Overview
Table 97. Sigma-Aldrich Corporation Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Sigma-Aldrich Corporation Thrombin (Human) Product
Table 99. Sigma-Aldrich Corporation Recent Developments/Updates
Table 100. Vitrolife AB Corporation Information
Table 101. Vitrolife AB Description and Business Overview
Table 102. Vitrolife AB Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Vitrolife AB Thrombin (Human) Product
Table 104. Vitrolife AB Recent Developments/Updates
Table 105. CSL Corporation Information
Table 106. CSL Description and Business Overview
Table 107. CSL Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. CSL Thrombin (Human) Product
Table 109. CSL Recent Developments/Updates
Table 110. Bayer Corporation Information
Table 111. Bayer Description and Business Overview
Table 112. Bayer Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Bayer Thrombin (Human) Product
Table 114. Bayer Recent Developments/Updates
Table 115. Grifols Corporation Information
Table 116. Grifols Description and Business Overview
Table 117. Grifols Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Grifols Thrombin (Human) Product
Table 119. Grifols Recent Developments/Updates
Table 120. Octapharma Corporation Information
Table 121. Octapharma Description and Business Overview
Table 122. Octapharma Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Octapharma Thrombin (Human) Product
Table 124. Octapharma Recent Developments/Updates
Table 125. Shanghai RAAS Corporation Information
Table 126. Shanghai RAAS Description and Business Overview
Table 127. Shanghai RAAS Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Shanghai RAAS Thrombin (Human) Product
Table 129. Shanghai RAAS Recent Developments/Updates
Table 130. Hualan Biological Corporation Information
Table 131. Hualan Biological Description and Business Overview
Table 132. Hualan Biological Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Hualan Biological Thrombin (Human) Product
Table 134. Hualan Biological Recent Developments/Updates
Table 135. Kedrion Corporation Information
Table 136. Kedrion Description and Business Overview
Table 137. Kedrion Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Kedrion Thrombin (Human) Product
Table 139. Kedrion Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Thrombin (Human) Distributors List
Table 143. Thrombin (Human) Customers List
Table 144. Thrombin (Human) Market Trends
Table 145. Thrombin (Human) Market Drivers
Table 146. Thrombin (Human) Market Challenges
Table 147. Thrombin (Human) Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Thrombin (Human)
Figure 2. Global Thrombin (Human) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Thrombin (Human) Market Share by Type in 2023 & 2030
Figure 4. 500IU/Vial Product Picture
Figure 5. 1000IU/Vial Product Picture
Figure 6. 2500IU/Vial Product Picture
Figure 7. Global Thrombin (Human) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Thrombin (Human) Market Share by Application in 2023 & 2030
Figure 9. Biotechnology
Figure 10. Medicine
Figure 11. Microbiology
Figure 12. Others
Figure 13. Global Thrombin (Human) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Thrombin (Human) Market Size (2019-2030) & (US$ Million)
Figure 15. Global Thrombin (Human) Sales (2019-2030) & (K Units)
Figure 16. Global Thrombin (Human) Average Price (USD/Unit) & (2019-2030)
Figure 17. Thrombin (Human) Report Years Considered
Figure 18. Thrombin (Human) Sales Share by Manufacturers in 2023
Figure 19. Global Thrombin (Human) Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Thrombin (Human) Players: Market Share by Revenue in 2023
Figure 21. Thrombin (Human) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Thrombin (Human) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Thrombin (Human) Sales Market Share by Country (2019-2030)
Figure 24. North America Thrombin (Human) Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Thrombin (Human) Sales Market Share by Country (2019-2030)
Figure 28. Europe Thrombin (Human) Revenue Market Share by Country (2019-2030)
Figure 29. Germany Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Thrombin (Human) Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Thrombin (Human) Revenue Market Share by Region (2019-2030)
Figure 36. China Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Thrombin (Human) Sales Market Share by Country (2019-2030)
Figure 47. Latin America Thrombin (Human) Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Thrombin (Human) Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Thrombin (Human) Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Thrombin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Thrombin (Human) by Type (2019-2030)
Figure 57. Global Revenue Market Share of Thrombin (Human) by Type (2019-2030)
Figure 58. Global Thrombin (Human) Price (USD/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Thrombin (Human) by Application (2019-2030)
Figure 60. Global Revenue Market Share of Thrombin (Human) by Application (2019-2030)
Figure 61. Global Thrombin (Human) Price (USD/Unit) by Application (2019-2030)
Figure 62. Thrombin (Human) Value Chain
Figure 63. Thrombin (Human) Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
